Etilbromazolam

Ethylbromazolam is a benzodiazepine derivative which has been sold as a designer drug. It is structurally similar to bromazolam, only differing by the substitution of the methyl group for an ethyl group on the triazole ring. It has been found in combination with its synthetic precursor desalkylgidazepam in samples expected to contain alprazolam alone. Its global presence, analytical characterisation and GABAA receptor activity has been described by researchers at Linköping University in collaboration with CanTEST, the Toronto Drug Checking Service, WEDINOS and others, finding ethylbromazolam has a similar in vitro potency to bromazolam.

Also known as: Ethyl Bromazolam

Classification

Chemical: Benzodiazepine
Psychoactive: Depressant

Effects

Sedation
Motor Impairment
Reduced Anxiety
Amnesia
Dulled Perception

Routes of Administration

No route information available yet.

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

wikipedia.org

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu